Alberta Claudia Undarsa
Alberta Claudia Undarsa has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Raymond Pranata
Faculty of Medicine Universitas Pelita Harapan Tangerang Indonesia
2 shared publications - Antonia Anna Lukito
Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia
1 shared publication - Artha Maressa Theodora Simanjuntak
Department of Medicine Faculty of Medicine, Public Health, and Nursing Universitas Gadjah Mada Yogyakarta Indonesia
1 shared publication - Astri Astuti
Department of Cardiology and Vascular Medicine, Dr. Hasan Sadikin General Hospital, Bandung, West Java, Indonesia.
1 shared publication - Christopher Daniel Tristan
Faculty of Medicine Surakarta Central Java Universitas Sebelas Maret
1 shared publication - Frengki Prabowo Saputro Wijayanto
Department of Medicine, Faculty of Medicine Public Health and Nursing Universitas Gadjah Mada Yogyakarta Indonesia
1 shared publication
Latest Publications
- 22 May 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 49 (9) , 1282-1293
Pacing‐Induced Cardiomyopathy in Leadless and Transvenous Pacemakers: A Meta‐Analysis and Meta‐Regression
Background: Leadless pacemakers have been developed to reduce complications associated with transvenous systems; however, their impact on pacing‐induced cardiomyopathy (PICM) remains uncertain. This study aimed to evaluate the prevalence of PICM following leadless pacing, compared PICM risk with transvenous pacing, and assessed cardiac resynchronization therapy (CRT) upgrade. Methods: This systematic review and meta‐analysis followed PRISMA guidelines. PubMed, Scopus, and ScienceDirect were searched up to January 2026. Studies reporting PICM following leadless pacing or comparing leadless and transvenous systems were included. Random‐effects models estimated pooled prevalence and risk ratios (RRs), and meta‐regression explored potential modifiers. Results: Eight studies comprising 3224 patients with leadless pacing were included. The pooled prevalence of PICM following leadless pacing was 13% (95%CI: 4%–23%; I 2 = 92%). In comparative analysis (5 studies; n = 6025), the risk of PICM was similar between leadless and transvenous pacing (RR 1.00; 95%CI: 0.77–1.29; I 2 = 52%). Leadless pacing was associated with a lower observed rate of CRT upgrade (RR 0.56; 95%CI: 0.48–0.66; I 2 = 42%), although this finding should be interpreted cautiously because it may reflect patient selection, procedural factors, and differing thresholds for CRT upgrade. Meta‐regression identified baseline heart failure (HF) as a significant predictor of PICM ( p < 0.0001). Conclusion: Leadless pacemakers demonstrate a non‐inferior risk of PICM and similar safety profiles to transvenous systems, while a lower observed rate of CRT upgrade. Future studies should standardize PICM definitions and improve reporting of pacing burden, ventricular function, and patient‐level outcomes.
- 22 May 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 49 (9) , 1282-1293
Pacing‐Induced Cardiomyopathy in Leadless and Transvenous Pacemakers: A Meta‐Analysis and Meta‐Regression
Background: Leadless pacemakers have been developed to reduce complications associated with transvenous systems; however, their impact on pacing‐induced cardiomyopathy (PICM) remains uncertain. This study aimed to evaluate the prevalence of PICM following leadless pacing, compared PICM risk with transvenous pacing, and assessed cardiac resynchronization therapy (CRT) upgrade. Methods: This systematic review and meta‐analysis followed PRISMA guidelines. PubMed, Scopus, and ScienceDirect were searched up to January 2026. Studies reporting PICM following leadless pacing or comparing leadless and transvenous systems were included. Random‐effects models estimated pooled prevalence and risk ratios (RRs), and meta‐regression explored potential modifiers. Results: Eight studies comprising 3224 patients with leadless pacing were included. The pooled prevalence of PICM following leadless pacing was 13% (95%CI: 4%–23%; I 2 = 92%). In comparative analysis (5 studies; n = 6025), the risk of PICM was similar between leadless and transvenous pacing (RR 1.00; 95%CI: 0.77–1.29; I 2 = 52%). Leadless pacing was associated with a lower observed rate of CRT upgrade (RR 0.56; 95%CI: 0.48–0.66; I 2 = 42%), although this finding should be interpreted cautiously because it may reflect patient selection, procedural factors, and differing thresholds for CRT upgrade. Meta‐regression identified baseline heart failure (HF) as a significant predictor of PICM ( p < 0.0001). Conclusion: Leadless pacemakers demonstrate a non‐inferior risk of PICM and similar safety profiles to transvenous systems, while a lower observed rate of CRT upgrade. Future studies should standardize PICM definitions and improve reporting of pacing burden, ventricular function, and patient‐level outcomes.
- Open Access
- 18 September 2024
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 12 (1) , 304-315
Meta-Analysis of Cardiac Magnetic Resonance in Prognosticating Left Ventricular Function in Peripartum Cardiomyopathy
Aims: Peripartum cardiomyopathy (PPCM) may result in a number of detrimental adverse cardiovascular events, notably persistent left ventricular ejection fraction (LVEF) reduction or even mortality. Imaging parameters on cardiac magnetic resonance (CMR) and their prognostic implications have rarely been perused in PPCM. We aimed to describe CMR’s prognostic value in predicting poor left ventricular (LV) function recovery using late gadolinium enhancement (LGE) and T2-weighted or T2 mapping. Methods and results: PubMed, Europe PMC, and ScienceDirect were screened for studies on late gadolinium enhancement (LGE) and myocardial oedema using CMR and PPCM. The outcome of interest was poor LV function recovery, with a follow-up period of at least 6 months. Comparisons between groups with the presence of LGE, myocardial oedema, and recovered against non-recovered patients were pooled. A random-effects model was employed to calculate the effect size. All pooled results were expressed as risk ratios (RRs) and 95% confidence intervals (CI). The area under the curve (AUC) was generated to test overall prognostic accuracy. Six cohort studies with 162 patients were included. The mean age of participants in this study was 30.6 years, and the majority of patients were diagnosed with PPCM after delivery. LGE was associated with a higher risk of poor LV function recovery, particularly when conducted at a later stage of disease (≥2.8 months) [RR = 2.83 (95% CI = 1.25–6.40); P = 0.001]. On the contrary, CMR conducted early (<2.8 months) exhibited a greater predictive value for myocardial oedema perceived by T2 mapping [RR = 3.44 (95% CI = 1.04–11.34); P = 0.043]. Diagnostic-test accuracy meta-analysis revealed that LGE had a sensitivity of 73% (95% CI, 56–85%), specificity of 79% (95% CI, 45–95%), and AUC of 0.78 (95% CI, 0.75–0.82) in predicting poor LV recovery when performed in the later phase, whereas significant myocardial oedema in those with non-recovered LV function had a sensitivity of 12% (95% CI, 2–52%), specificity of 68% (95% CI, 39–88%), and AUC of 0.40 (95% CI, 0.36–0.44) while undertaken in the latter phase. Our findings support the notion that inflammation plays a significant role in PPCM and that alterations to tissue composition occur in a time-dependent manner. Conclusions: Contrast-enhanced CMR can be utilized as an adjunct examination in post-partum PPCM patients to stratify the risk of poor LV function recovery while conducted at a suitable point in time.
- 18 September 2024
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 12 (1) , 304-315
Open AccessMeta-Analysis of Cardiac Magnetic Resonance in Prognosticating Left Ventricular Function in Peripartum Cardiomyopathy
Aims: Peripartum cardiomyopathy (PPCM) may result in a number of detrimental adverse cardiovascular events, notably persistent left ventricular ejection fraction (LVEF) reduction or even mortality. Imaging parameters on cardiac magnetic resonance (CMR) and their prognostic implications have rarely been perused in PPCM. We aimed to describe CMR’s prognostic value in predicting poor left ventricular (LV) function recovery using late gadolinium enhancement (LGE) and T2-weighted or T2 mapping. Methods and results: PubMed, Europe PMC, and ScienceDirect were screened for studies on late gadolinium enhancement (LGE) and myocardial oedema using CMR and PPCM. The outcome of interest was poor LV function recovery, with a follow-up period of at least 6 months. Comparisons between groups with the presence of LGE, myocardial oedema, and recovered against non-recovered patients were pooled. A random-effects model was employed to calculate the effect size. All pooled results were expressed as risk ratios (RRs) and 95% confidence intervals (CI). The area under the curve (AUC) was generated to test overall prognostic accuracy. Six cohort studies with 162 patients were included. The mean age of participants in this study was 30.6 years, and the majority of patients were diagnosed with PPCM after delivery. LGE was associated with a higher risk of poor LV function recovery, particularly when conducted at a later stage of disease (≥2.8 months) [RR = 2.83 (95% CI = 1.25–6.40); P = 0.001]. On the contrary, CMR conducted early (<2.8 months) exhibited a greater predictive value for myocardial oedema perceived by T2 mapping [RR = 3.44 (95% CI = 1.04–11.34); P = 0.043]. Diagnostic-test accuracy meta-analysis revealed that LGE had a sensitivity of 73% (95% CI, 56–85%), specificity of 79% (95% CI, 45–95%), and AUC of 0.78 (95% CI, 0.75–0.82) in predicting poor LV recovery when performed in the later phase, whereas significant myocardial oedema in those with non-recovered LV function had a sensitivity of 12% (95% CI, 2–52%), specificity of 68% (95% CI, 39–88%), and AUC of 0.40 (95% CI, 0.36–0.44) while undertaken in the latter phase. Our findings support the notion that inflammation plays a significant role in PPCM and that alterations to tissue composition occur in a time-dependent manner. Conclusions: Contrast-enhanced CMR can be utilized as an adjunct examination in post-partum PPCM patients to stratify the risk of poor LV function recovery while conducted at a suitable point in time.
- Open Access
- 19 August 2018
- Published by Indonesian Journal of Cardiology in Indonesian Journal of Cardiology
- Vol. 38 (4) , 195-201
Correlation of Waist to Height Ratio with Leptin Serum Level in Coronary Artery Disease
Background: Adiposity assessment plays an important role in coronary artery disease (CAD) prevention. One of the adiposity parameter in major CAD management guideline is waist to height ratio (WHtR). Adiposity promotes the pathogenesis of coronary atherosclerosis by involving adipokines released by adipose tissue. Leptin is obesity identic adipokine which is used as prognostic predictor of cardiovascular event. This study aims to analyze correlation between WHtR and leptin serum level. Method: A cross sectional study was performed to 37 stable CAD patients undergone elective coronary angiography in Heart Catheterization Laboratory Dr Hasan Sadikin Hospital, Bandung, West java in July 2014 Results: Mean age of the subjects was 56.7± 9.12 years old with mean age of men (n=32) and women (n=5) were 55.9±9.47 years old and 62±3.54 years old consecutively. There were 30 (81%) subjects classified as obese (WHtR≥0.5) with mean WHtR 0.54±0,06. Median value of leptin serum was 8599.90 pg/ml (780-36929.3 pg/ml). Based on rank-spearman correlation test, a positive moderate correlation was significantly found between WHtR and Leptin serum level (Spearman’s rho = 0.5, p= 0.001). Conclusion: Positive correlation was found between WHtR and leptin serum level. Hence, WHtR might be useful as indicator of leptin serum level which has been used as a prognostic biomarker in CAD patients Abstrak Latar belakang: Penilaian adipositas merupakan bagian dari upaya preventif penyakit jantung koroner (PJK). Salah satu parameter antropometri adipositas yang digunakan pada panduan tatalaksana PJK adalah pengukuran rasio lingkar pinggang/tinggi badan (LP/TB). Adipositas diketahui berperan dalam patomekanisme terbentuknya aterosklerosis koroner melalui pelepasan adipositokin oleh jaringan adiposa. Leptin merupakan adipositokin identik adiposit yang digunakan sebagai biomarka indikator prognostik kejadian kardiovaskular. Penelitian ini bertujuan untuk menganalisa korelasi LP/TB dengan kadar leptin serum. Metode: Studi potong lintang dengan menganalisis antropometri LP/TB dan kadar leptin serum pada 37 pasien PJK yang menjalani angiografi elektif di Laboratorium Kateterisasi Jantung RSUP Dr.Hasan Sadikin, Bandung, Jawa Barat pada bulan Juli 2014. Hasil: Rerata usia subjek adalah 56.7± 9.12 tahun dengan rerata usia pria (n=32) dan wanita (n=5) secara berurutan adalah 55.9±9.47 tahun dan 62±3.54 tahun. Terdapat 30 (81%) subjek tergolong obesitas (nilai LP/TB ≥0,5) dengan rata-rata LP/TB 0.54±0,06. Nilai median leptin serum 8599.90 pg/ml (780-36929.3 pg/ml). Berdasarkan uji korelasi rank-spearman, terdapat korelasi positif bermakna antara LP/TB dengan kadar leptin serum (Spearman rho = 0.5, p= 0.001). Kesimpulan: Terdapat korelasi positif bermakna antara pemeriksaan antropometri LP/TB dengan kadar leptin serum. Rasio lingkar pinggang/tinggi badan dapat digunakan sebagai salah satu indikator kadar leptin serum yang merupakan biomarka prognostik kardiovaskular.
- 19 August 2018
- Published by Indonesian Journal of Cardiology in Indonesian Journal of Cardiology
- Vol. 38 (4) , 195-201
Open AccessCorrelation of Waist to Height Ratio with Leptin Serum Level in Coronary Artery Disease
Background: Adiposity assessment plays an important role in coronary artery disease (CAD) prevention. One of the adiposity parameter in major CAD management guideline is waist to height ratio (WHtR). Adiposity promotes the pathogenesis of coronary atherosclerosis by involving adipokines released by adipose tissue. Leptin is obesity identic adipokine which is used as prognostic predictor of cardiovascular event. This study aims to analyze correlation between WHtR and leptin serum level. Method: A cross sectional study was performed to 37 stable CAD patients undergone elective coronary angiography in Heart Catheterization Laboratory Dr Hasan Sadikin Hospital, Bandung, West java in July 2014 Results: Mean age of the subjects was 56.7± 9.12 years old with mean age of men (n=32) and women (n=5) were 55.9±9.47 years old and 62±3.54 years old consecutively. There were 30 (81%) subjects classified as obese (WHtR≥0.5) with mean WHtR 0.54±0,06. Median value of leptin serum was 8599.90 pg/ml (780-36929.3 pg/ml). Based on rank-spearman correlation test, a positive moderate correlation was significantly found between WHtR and Leptin serum level (Spearman’s rho = 0.5, p= 0.001). Conclusion: Positive correlation was found between WHtR and leptin serum level. Hence, WHtR might be useful as indicator of leptin serum level which has been used as a prognostic biomarker in CAD patients Abstrak Latar belakang: Penilaian adipositas merupakan bagian dari upaya preventif penyakit jantung koroner (PJK). Salah satu parameter antropometri adipositas yang digunakan pada panduan tatalaksana PJK adalah pengukuran rasio lingkar pinggang/tinggi badan (LP/TB). Adipositas diketahui berperan dalam patomekanisme terbentuknya aterosklerosis koroner melalui pelepasan adipositokin oleh jaringan adiposa. Leptin merupakan adipositokin identik adiposit yang digunakan sebagai biomarka indikator prognostik kejadian kardiovaskular. Penelitian ini bertujuan untuk menganalisa korelasi LP/TB dengan kadar leptin serum. Metode: Studi potong lintang dengan menganalisis antropometri LP/TB dan kadar leptin serum pada 37 pasien PJK yang menjalani angiografi elektif di Laboratorium Kateterisasi Jantung RSUP Dr.Hasan Sadikin, Bandung, Jawa Barat pada bulan Juli 2014. Hasil: Rerata usia subjek adalah 56.7± 9.12 tahun dengan rerata usia pria (n=32) dan wanita (n=5) secara berurutan adalah 55.9±9.47 tahun dan 62±3.54 tahun. Terdapat 30 (81%) subjek tergolong obesitas (nilai LP/TB ≥0,5) dengan rata-rata LP/TB 0.54±0,06. Nilai median leptin serum 8599.90 pg/ml (780-36929.3 pg/ml). Berdasarkan uji korelasi rank-spearman, terdapat korelasi positif bermakna antara LP/TB dengan kadar leptin serum (Spearman rho = 0.5, p= 0.001). Kesimpulan: Terdapat korelasi positif bermakna antara pemeriksaan antropometri LP/TB dengan kadar leptin serum. Rasio lingkar pinggang/tinggi badan dapat digunakan sebagai salah satu indikator kadar leptin serum yang merupakan biomarka prognostik kardiovaskular.